Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Fraser, G, Cramer, P, Demirkan, F, Silva, R Santucci, Grosicki, S, Pristupa, A, Janssens, A, Mayer, J, Bartlett, N L, Dilhuydy, M-S, Pylypenko, H, Loscertales, J, Avigdor, A, Rule, S, Villa, D, Samoilova, O, Panagiotidis, P, Goy, A, Pavlovsky, M A, Karlsson, C, Hallek, M, Mahler, M, Salman, M, Sun, S, Phelps, C, Balasubramanian, S, Howes, A, Chanan-Khan, A
Published in Leukemia (01.04.2019)
Published in Leukemia (01.04.2019)
Get full text
Journal Article
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
Bartlett, NL, Niedzwiecki, D, Johnson, JL, Friedberg, JW, Johnson, KB, van Besien, K, Zelenetz, AD, Cheson, BD, Canellos, GP
Published in Annals of oncology (01.06.2007)
Published in Annals of oncology (01.06.2007)
Get full text
Journal Article
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience
Hong, F., Habermann, T.M., Gordon, L.I., Hochster, H., Gascoyne, R.D., Morrison, V.A., Fisher, R.I., Bartlett, N.L., Stiff, P.J., Cheson, B.D., Crump, M., Horning, S.J., Kahl, B.S.
Published in Annals of oncology (01.03.2014)
Published in Annals of oncology (01.03.2014)
Get full text
Journal Article
Serious pulmonary toxicity in patients with Hodgkin’s lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism
Blum, K.A., Jung, S.-H., Johnson, J.L., Lin, T.S., Hsi, E.D., Lucas, D.M., Byrd, J.C., Cheson, B.D., Bartlett, N.L.
Published in Annals of oncology (01.11.2010)
Published in Annals of oncology (01.11.2010)
Get full text
Journal Article
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
Horwitz, S., O'Connor, O.A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N.L., Christensen, J.H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W.S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S.-P., Shustov, A., Hüttmann, A., Savage, K.J., Yuen, S., Zinzani, P.L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., Illidge, T.
Published in Annals of oncology (01.03.2022)
Published in Annals of oncology (01.03.2022)
Get full text
Journal Article
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)
Martin, P., Jung, S.-H., Pitcher, B., Bartlett, N.L., Blum, K.A., Shea, T., Hsi, E.D., Ruan, J., Smith, S.E., Leonard, J.P., Cheson, B.D.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
Cottereau, A S, Rebaud, L, Trotman, J, Feugier, P, Nastoupil, L J, Bachy, E, Flinn, I W, Haioun, C, Ysebaert, L, Bartlett, N L, Tilly, H, Casasnovas, O, Ricci, R, Portugues, C, Buvat, I, Meignan, M, Morschhauser, F
Published in Annals of oncology (01.01.2024)
Published in Annals of oncology (01.01.2024)
Get full text
Journal Article
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
Bartlett, N L, Lum, B L, Fisher, G A, Brophy, N A, Ehsan, M N, Halsey, J, Sikic, B I
Published in Journal of clinical oncology (01.04.1994)
Published in Journal of clinical oncology (01.04.1994)
Get more information
Journal Article
Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492
HORNING, S. J, WILLIAMS, J, BARTLETT, N. L, BENNETT, J. M, HOPPE, R. T, NEUBERG, D, CASSILETH, P
Published in Journal of clinical oncology (01.03.2000)
Published in Journal of clinical oncology (01.03.2000)
Get full text
Journal Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA
Rebaud, L., Capobianco, N., Spottiswoode, B., Cottereau, A., Trotman, J., Feugier, P., Nastoupil, L. J., Bachy, E., Flinn, I. W., Haioun, C., Ysebaert, L., Bartlett, N. L., Tilly, H., Casasnovas, R., Ricci, R., Portugues, C., Meignan, M., Morschhauser, F., Buvat, I.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy
Caimi, P. F., Cashen, A., Gallogly, M., Winter, A., Boughan, K., Ghobadi, A., Jagadeesh, D., Cooper, B., Mehta‐Shah, N., Dean, R., Metheny, L., Pohlman, B., Bartlett, N. L., Lima, M., Kahl, B. S., Hill, B. T.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN SUBJECTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (TRIAL IN PROGRESS)
Bartlett, N. L., Yasenchak, C. A., Ashraf, K. K., Harwin, W. N., Sims, R. B., Nowakowski, G. S.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE AND SHOWS EARLY EFFICACY IN PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA
Hutchings, M., Dickinson, M., Carlo‐Stella, C., Morschhauser, F., Bosch, F., Gritti, G., Townsend, W., Bartlett, N. L., Cartron, G., Ghesquieres, H., Houot, R., Walter, H., Offner, F., Christiansen, A., Dimier, N., Jamois, C., Harrop, E., Herter, S., Hölzlwimmer, G., Keelara, A., Korfi, K., Luong, J., Mueller, C., Mycroft, S., Whayman, M., Prieto, I., Rukina, D., Lechner, K.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY
Sehn, L. H., Bartlett, N. L., Matasar, M., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Shadman, M., Cheah, C. Y., Fay, K., Ku, M., Nastoupil, L., Wei, M. C., Yin, S., To, I., Hu, N., Min, J., Penuel, E., Belousov, A., Coimbra, A., Jemaa, S., Bender, B., Turner, D., Budde, L. E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
An Atom Probe Study of κ-carbide Precipitation in Austenitic Lightweight Steel and the Effect of Phosphorus
Bartlett, L. N., Van Aken, D. C., Medvedeva, J., Isheim, D., Medvedeva, N., Song, K.
Published in Metallurgical and materials transactions. A, Physical metallurgy and materials science (01.11.2017)
Published in Metallurgical and materials transactions. A, Physical metallurgy and materials science (01.11.2017)
Get full text
Journal Article
BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON‐1 STUDY
Crosswell, H. E, LaCasce, A. S., Bartlett, N. L, Straus, D. J, Savage, K. J, Zinzani, P. L, Collins, G. P, Fanale, M. A, Fenton, K, Dong, C, Miao, H. H, Grigg, A. P
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
NIVOLUMAB(N)‐AVD IMPROVES PROGRESSION‐FREE SURVIVAL COMPARED TO BRENTUXIMAB VEDOTIN(BV)‐AVD IN ADVANCED STAGE (AS) CLASSIC HODGKIN LYMPHOMA (HL): RESULTS OF SWOG S1826
Herrera, A. F., LeBlanc, M., Castellino, S. M., Li, H., Rutherford, S. C., Evens, A. M., Davison, K., Punnett, A., Hodgson, D., Parsons, S. K., Ahmed, S., Casulo, C., Bartlett, N. L., Tuscano, J. M., Mei, M. G., Hess, B. T., Jacobs, R., Saeed, H., Torka, P., Hu, B., Moskowitz, C., Kaur, S., Goyal, G., Forlenza, C., Doan, A., Lamble, A., Kumar, P., Chowdhury, S., Brinker, B., Sharma, N., Singh, A., Blum, K., Perry, A. M., Kovach, A., Constine, L. S., Shields, L. Kostakoglu, Prica, A., Little, R. F., Shipp, M. A., Crump, M., Kahl, B., Leonard, J. P., Smith, S. M., Song, J. Y., Kelly, K. M., Friedberg, J. W.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)
Zinzani, P. L., Carlo‐Stella, C., Hamadani, M., Herrera, A. F., Ansell, S. M., Radford, J., Maddocks, K., Kline, J., Savage, K. J., Bartlett, N. L., Caimi, P. F., Negievich, Y., Cruz, H. G., Wang, L., Wuerthner, J., Collins, G. P.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)
LaCasce, A. S., Dockter, T., Ruppert, A., Kostakoglu, L., Schöder, H., Hsi, E. D., Bogart, J. A., Cheson, B. D., Wagner‐Johnston, N. D., Abramson, J. S., Maddocks, K. J., Leonard, J. P., Bartlett, N. L.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article